The HCV NS3/4A protease inhibitor glecaprevir plus the HCV NS5A inhibitor pibrentasvir is one of two recommended regimens for simplified HCV treatment in eligible patients. The other recommended regimen is the NS5B polymerase inhibitor sofosbuvir plus velpatasvir, a HCV NS5A replication complex inhibitor. These drugs are among the available direct-acting antiviral agents for HCV therapy.
Learn more about the treatment of nonresponsive or relapsing HCV infection.
Medscape © 2021 WebMD, LLC
Cite this: Fast Five Quiz: Are You Prepared to Confront Hepatitis C? - Medscape - Jun 04, 2021.